Trigeminal Nerve Diseases: Clinical Trials

11 trials for Trigeminal Nerve Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 6, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Trigeminal Nerve Diseases: new trials by email Literature Review of Trigeminal Nerve Diseases trials Research Report on Trigeminal Nerve Diseases

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia
Oxcarbazepine, Carbamazepine - Trigeminal Neuralgia
Phase 4Active not recruitingJinnah Postgraduate Medical Centre1222024-09-212025-03-04
OnabotulinumtoxinA for Trigeminal Neuralgia
OnabotulinumtoxinA 100 UNT [Botox], Sodium Chloride 0.9% for Injection, Preservative Free - Trigeminal Neuralgia
Phase 4RecruitingStanford University202024-06-012026-01-22
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
Oxcarbazepine, Carbamazepine - Trigeminal Neuralgia
Phase 4UnknownPostgraduate Institute of Dental Sciences Rohtak1322021-09-182021-10-15
5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia
5% lidocaine medicated plaster, vehicle plaster - Trigeminal Neuralgia
Phase 4CompletedBeijing Tiantan Hospital2262021-05-012023-03-14
Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
Galcanezumab - Trigeminal Neuralgia, Glossopharyngeal Neuralgia
Phase 4CompletedDuke University262020-07-242026-02-02
Does Low-level Laser Therapy Protocol Affect the Efficacy of Treatment of Inferior Alveolar Nerve Injury After Maxillofacial Surgery
Low Level Laser Therapy - Inferior Alveolar Nerve Injuries
Phase 4CompletedKaradeniz Technical University552019-01-152025-03-25
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Oxtellar XR 150Mg Extended Release Tablet - Trigeminal Neuralgia
Phase 4WithdrawnUniversity of Colorado, Denver2018-12-142019-11-01
(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
Botulinum toxin type A - Migraine
Phase 4CompletedMassachusetts General Hospital372017-12-012025-03-24
Postoperative Analgesia in Patients With Microvascular Decompression
Ketamine, scalp nerve block, ondansetron - Trigeminal Neuralgia
Phase 4UnknownXiangya Hospital of Central South University902017-05-152018-05-15
Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain
Low Intensity Low Frequency Surface Acoustic Wave Ultrasound (PainShield™) - Trigeminal Neuralgia, Tic Douloureux
Phase 4CompletedSheba Medical Center162011-11-012012-12-27
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)
COA566 - Malaria
Phase 4CompletedNovartis140752010-11-012014-02-10

Narrower conditions

Trigeminal Neuralgia (10)  ·  Glossopharyngeal Nerve Diseases (1)  ·  Malaria (1)  ·  Mandibular Nerve Injuries (1)  ·  Migraine Disorders (1)

Broader conditions

Cranial Nerve Diseases (11)  ·  Facial Nerve Diseases (11)  ·  Facial Neuralgia (11)  ·  Mouth Diseases (11)  ·  Nervous System Diseases (11)  ·  Stomatognathic Diseases (11)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cranial Nerve Injuries (1)  ·  Craniocerebral Trauma (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Infections (1)  ·  Mosquito-Borne Diseases (1)

Interventions

Oxcarbazepine (3)  ·  Botulinum Toxins, Type A (2)  ·  Carbamazepine (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Injections (1)  ·  Ketamine (1)  ·  Low-Level Light Therapy (1)  ·  Ondansetron (1)  ·  Sodium Chloride (1)  ·  Sufentanil (1)  ·  galcanezumab (1)  ·  zileuton (1)

Sponsors

Beijing Tiantan Hospital (1)  ·  Duke University (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Karadeniz Technical University (1)  ·  Massachusetts General Hospital (1)  ·  Novartis (1)  ·  Postgraduate Institute of Dental Sciences Rohtak (1)  ·  Sheba Medical Center (1)  ·  Stanford University (1)  ·  University of Colorado, Denver (1)  ·  Xiangya Hospital of Central South University (1)

Countries

United States (3)  ·  China (2)  ·  Burkina Faso (1)  ·  India (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Dr. Rizwana Malahat Ahmad, MBBS (1)  ·  Fang Luo (1)  ·  Jacquelyn Bainbridge, PharmD (1)  ·  Manuel Zwecker, MD (1)  ·  Meredith Barad, MD (1)  ·  Sweta Sengupta, MD (1)  ·  William G. Austen, MD (1)  ·  Xie Yongqiu (1)

Results publications

PMID 10630935, PMID 15225944, PMID 15464564, PMID 16480503, PMID 18088730, PMID 19146143, PMID 20521077, PMID 24215306, PMID 28538060, PMID 29022844, PMID 30509397, PMID 32181610, PMID 34341037, PMID 39193836